10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
14.01
-0.27 (-1.89%)
At close: Aug 29, 2025, 4:00 PM
14.19
+0.18 (1.28%)
After-hours: Aug 29, 2025, 7:55 PM EDT
10x Genomics Market Cap
10x Genomics has a market cap or net worth of $1.74 billion as of August 29, 2025. Its market cap has decreased by -26.75% in one year.
Market Cap
1.74B
Enterprise Value
1.38B
1-Year Change
-26.75%
Ranking
Category
Stock Price
$14.01
Market Cap Chart
Since September 12, 2019, 10x Genomics's market cap has decreased from $4.95B to $1.74B, a decrease of -64.77%. That is a compound annual growth rate of -16.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 1.74B | 0.33% |
| Dec 31, 2024 | 1.74B | -73.72% |
| Dec 29, 2023 | 6.61B | 58.59% |
| Dec 30, 2022 | 4.17B | -74.93% |
| Dec 31, 2021 | 16.64B | 9.21% |
| Dec 31, 2020 | 15.24B | 107.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |